These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8164837)

  • 61. Differential recovery of dopamine synthetic enzymes following MPTP and the consequences of GM1 ganglioside treatment.
    Hadjiconstantinou M; Neff NH
    Eur J Pharmacol; 1990 May; 181(1-2):137-9. PubMed ID: 1974854
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Continued administration of GM1 ganglioside is required to maintain recovery from neuroleptic-induced sensorimotor deficits in MPTP-treated mice.
    Weihmuller FB; Hadjiconstantinou M; Bruno JP; Neff NH
    Life Sci; 1989; 45(25):2495-502. PubMed ID: 2532697
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Neurochemical evaluation of the striatum in symptomatic and recovered MPTP-treated cats.
    Schneider JS; Rothblat DS
    Neuroscience; 1991; 44(2):421-9. PubMed ID: 1944893
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Lack of mitigation of methamphetamine-induced neurotoxicity by ganglioside GM1 or vitamin E.
    Ali SF
    Ann N Y Acad Sci; 1995 Sep; 765():311. PubMed ID: 7486624
    [No Abstract]   [Full Text] [Related]  

  • 65. Repeated exposure to MPTP does not produce a permanent movement disorder in cats recovered from MPTP-induced parkinsonism.
    Rothblat DS; Schneider JS
    Neurodegeneration; 1995 Mar; 4(1):87-92. PubMed ID: 7600188
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The effects of deprenyl on methamphetamine-induced dopamine depletions.
    Johnson SK; Medina D; Wagner GC
    J Neural Transm Gen Sect; 1992; 89(1-2):123-7. PubMed ID: 1418863
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Enhanced susceptibility to kainate-induced seizures, neuronal apoptosis, and death in mice lacking gangliotetraose gangliosides: protection with LIGA 20, a membrane-permeant analog of GM1.
    Wu G; Lu ZH; Wang J; Wang Y; Xie X; Meyenhofer MF; Ledeen RW
    J Neurosci; 2005 Nov; 25(47):11014-22. PubMed ID: 16306414
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Molecular parameters of semisynthetic derivatives of gangliosides and sphingosine in monolayers at the air-water interface.
    Perillo MA; Polo A; Guidotti A; Costa E; Maggio B
    Chem Phys Lipids; 1993 Oct; 65(3):225-38. PubMed ID: 8269552
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Parkinsonism caused by petroleum waste ingestion.
    Tetrud JW; Langston JW; Irwin I; Snow B
    Neurology; 1994 Jun; 44(6):1051-4. PubMed ID: 8208398
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Metabolism of semisynthetic single-chain GM1 derivatives in cerebellar granule cells in culture.
    Pitto M; Miglio A; Kirschner G; Leon A; Ghidoni R
    Neurochem Res; 1991 Nov; 16(11):1187-92. PubMed ID: 1815134
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Synthesis and use of caged sphingolipids.
    Scott RH; Pollock J; Ayar A; Thatcher NM; Zehavi U
    Methods Enzymol; 2000; 312():387-400. PubMed ID: 11070887
    [No Abstract]   [Full Text] [Related]  

  • 72. Glycosphingolipids.
    Chiricozzi E; Aureli M; Mauri L; Di Biase E; Lunghi G; Fazzari M; Valsecchi M; Carsana EV; Loberto N; Prinetti A; Sonnino S
    Adv Exp Med Biol; 2021; 1325():61-102. PubMed ID: 34495530
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Dysregulated Lipid Metabolism and Its Role in α-Synucleinopathy in Parkinson's Disease.
    Alecu I; Bennett SAL
    Front Neurosci; 2019; 13():328. PubMed ID: 31031582
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The Neuroprotective Role of the GM1 Oligosaccharide, II
    Chiricozzi E; Maggioni M; di Biase E; Lunghi G; Fazzari M; Loberto N; Elisa M; Scalvini FG; Tedeschi G; Sonnino S
    Mol Neurobiol; 2019 Oct; 56(10):6673-6702. PubMed ID: 30911934
    [TBL] [Abstract][Full Text] [Related]  

  • 75. MPTP-induced executive dysfunction is associated with altered prefrontal serotonergic function.
    Maiti P; Gregg LC; McDonald MP
    Behav Brain Res; 2016 Feb; 298(Pt B):192-201. PubMed ID: 26393431
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A single intramuscular injection of rAAV-mediated mutant erythropoietin protects against MPTP-induced parkinsonism.
    Dhanushkodi A; Akano EO; Roguski EE; Xue Y; Rao SK; Matta SG; Rex TS; McDonald MP
    Genes Brain Behav; 2013 Mar; 12(2):224-33. PubMed ID: 23190369
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mice lacking major brain gangliosides develop parkinsonism.
    Wu G; Lu ZH; Kulkarni N; Amin R; Ledeen RW
    Neurochem Res; 2011 Sep; 36(9):1706-14. PubMed ID: 21399908
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models.
    Steiner JP; Hamilton GS; Ross DT; Valentine HL; Guo H; Connolly MA; Liang S; Ramsey C; Li JH; Huang W; Howorth P; Soni R; Fuller M; Sauer H; Nowotnik AC; Suzdak PD
    Proc Natl Acad Sci U S A; 1997 Mar; 94(5):2019-24. PubMed ID: 9050897
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Oral administration of semisynthetic sphingolipids promotes recovery of striatal dopamine concentrations in a murine model of parkinsonism.
    Schneider JS; DiStefano L
    Neurology; 1994 Apr; 44(4):748-50. PubMed ID: 8164837
    [TBL] [Abstract][Full Text] [Related]  

  • 80. LIGA 20 increases striatal dopamine levels in aged MPTP-treated mice refractory to GM1 ganglioside treatment.
    Schneider JS; DiStefano L
    Neuroreport; 1993 Nov; 5(2):103-4. PubMed ID: 8110995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.